Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Allergan is recalling 56,878 bottles of Lumigan (bimatoprost) 0.01% ophthalmic solution because the product failed impurities and degradation specifications.
Jubilant Cadista Pharmaceuticals is recalling Bupropion Hydrochloride Extended-release Tablets because high levels of a degradation product were detected.
West-Ward Columbus, Inc. is recalling Doxercalciferol Capsules 0.5mcg because capsules were found with illegible print during an internal inspection.
Jubilant Cadista Pharmaceuticals is recalling specific lots of Bupropion Hydrochloride Extended-release Tablets due to high levels of a degradation product.
X-Gen Pharmaceuticals is recalling 2,593 cartons of Ibuprofen Lysine Injection because of the presence of particulate matter. The affected product was distributed nationwide in the USA.
SCA Pharmaceuticals is recalling Vancomycin HCl IV bags due to the presence of particulate matter, linked to a related Hospira recall.
SCA Pharmaceuticals is recalling 490 bags of Vancomycin HCl IV solution due to the presence of particulate matter, linked to a related Hospira recall.
SCA Pharmaceuticals is recalling specific lots of Vancomycin HCl IV bags due to the presence of particulate matter, following a related Hospira recall.
Organic Herbal Supply is recalling XtraHRD Natural Male Enhancement Capsules because they contain N-desmethyl tadalafil, an unapproved drug ingredient.
SCA Pharmaceuticals is recalling 50 bags of Vancomycin HCl 1.5 gram IV bags due to the presence of particulate matter.
Shire is recalling specific lots of Kalbitor (ecallantide) injection because glass particles were found in the product.
Genentech is recalling 748 bottles of Cotellic (cobimetinib) tablets because an oversized tablet was found in a bottle. The affected product was distributed in New Jersey and Illinois.
SCA Pharmaceuticals is recalling 50 bags of Vancomycin HCl 1.25 g in 5% Dextrose 250 mL due to the presence of particulate matter.
Hospira is recalling 30,880 vials of Vancomycin Hydrochloride for Injection because a hair was found inside a vial and contacted the drug.
SCA Pharmaceuticals is recalling 716 bags of Vancomycin HCl IV solution due to the presence of particulate matter.
SCA Pharmaceuticals is recalling 62 bags of Vancomycin HCl 750 mg IV bags due to the presence of particulate matter.
Alvogen, Inc. is recalling Adalat CC (nifedipine) 90 mg extended-release tablets because residual sorafenib powder was found in the manufacturing equipment's inlet air duct.
GlaxoSmithKline is recalling 593,088 Ventolin inhalers because some units have out-of-specification leak rates, potentially affecting drug delivery.
Alvogen, Inc. is recalling specific lots of Adalat CC (nifedipine) Extended-Release Tablets due to cross-contamination with sorafenib powder.
Alvogen Inc. is recalling Nifedipine Extended-Release Tablets, 90 mg, due to cross-contamination with sorafenib powder found in the inlet air duct.
Alvogen, Inc. is recalling Adalat CC (nifedipine) Extended Release Tablets due to cross-contamination with sorafenib powder found in the manufacturing facility.
Alvogen, Inc. is recalling Adalat CC (nifedipine) Extended Release Tablets 30 mg due to cross-contamination with sorafenib powder.
Alvogen, Inc. is recalling Nifedipine Extended-Release Tablets, 30 mg, due to cross-contamination with sorafenib powder found in the manufacturing facility's inlet air duct.
Fresenius Kabi USA is recalling 118,224 vials of Fluphenazine Decanoate Injection because the drug was found to be subpotent.
Lupin Pharmaceuticals is recalling Quinapril 5 mg tablets because they failed impurity specifications. The recall covers 15,168 bottles distributed nationwide.